Breaking News Instant updates and real-time market news.

EBAY

eBay

$37.95

(0.00%)

, IBM

IBM

$144.44

(0.00%)

09:40
07/19/18
07/19
09:40
07/19/18
09:40

Unusually active option classes on open July 19th

Unusual total active option classes on open include: EBay (EBAY), IBM (IBM), FMC Technologies (FTI), United Rentals (URI), AbbVie (ABBV), Alcoa (AA), American Express (AXP), Philip Morris (PM), Blackstone (BX), and Consumer Staples Sector SPDR ETF (XLP).

EBAY

eBay

$37.95

(0.00%)

IBM

IBM

$144.44

(0.00%)

FTI

TechnipFMC

$30.94

(0.00%)

URI

United Rentals

$155.14

(0.00%)

ABBV

AbbVie

$94.40

(0.00%)

AA

Alcoa

$47.90

(0.00%)

AXP

American Express

$102.98

(0.00%)

PM

Philip Morris

$82.16

(0.00%)

BX

Blackstone

$36.23

(0.00%)

XLP

Consumer Staples Sector SPDR

$52.55

(0.00%)

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 26

    Jul

  • 27

    Jul

  • 06

    Aug

  • 08

    Aug

EBAY eBay
$37.95

(0.00%)

07/19/18
07/19/18
DOWNGRADE
Target $46

Outperform
eBay downgraded to Outperform, buy on the pullback, says Raymond James
As previously reported, Raymond James downgraded eBay to Outperform from Strong Buy and lowered its price target to $46 from $51. Analyst Aaron Kessler said Marketplace initiatives are ramping slower than expected, with a likely acceleration now in 2019, and StubHub growth near-term is likely to remain challenging. Kessler would be a buyer of eBay on this pullback as he continues to expect an improving story driven by product based experiences, Promoted Listings uptake, and Payment initiative progress.
07/19/18
RBCM
07/19/18
NO CHANGE
Target $47
RBCM
Outperform
eBay price target lowered to $47 from $51 at RBC Capital
RBC Capital analyst Mark Mahaney lowered his price target on eBay $47 after its mixed Q2 results, saying the company's marketplace and StubHub gross merchandise volume trends were soft because of a "limited impact" from its marketing initiatives and weak ticket markets. The analyst keeps his Outperform rating, albeit with a "less constructive" stance, noting that eBay can accelerate GMV growth in U.S. and Europe to high-single digits and also generate new revenue from intermediated payments through its Ayden partnership. Mahaney also notes that eBay can further ramp up its stock buybacks to boost EPS growth.
07/19/18
STFL
07/19/18
NO CHANGE
Target $43
STFL
Hold
eBay modestly reduced revenue guidance 'as feared,' says Stifel
Stifel analyst Scott Devitt noted that, "as feared," eBay modestly reduced its full-year revenue guidance, but also said it expects core GMV acceleration in the second half. While he thinks the risk/reward profile is becoming more attractive, Devitt keeps a Hold rating on eBay and trimmed his price target on the stock to $43 from $44.
07/19/18
BARD
07/19/18
NO CHANGE
Target $44
BARD
Outperform
eBay price target lowered to $44 from $52 at Baird
Baird analyst Colin Sebastian lowered his price target on eBay to $44 from $52 following mixed Q2 results. The analyst said risks remain elevated through the second half of the year, but he believes that may already be reflected in the share price. He admits the shares are now in the "show-me" category as platform improvements are only modestly improving growth, which management expects to accelerate in the second half. Sebastian maintained his Outperform rating on eBay shares.
IBM IBM
$144.44

(0.00%)

07/19/18
BMOC
07/19/18
NO CHANGE
Target $172
BMOC
IBM Q2 Cognitive segment results 'disappointing', says BMO Capital
BMO Capital analyst Keith Bachman lowered his price target on IBM to $172 from $175 and kept his Market Perform rating after its Q2 results. The analyst notes that while the company saw some progress on the services side and the Systems performance was better than expected, the Cognitive segment results were disappointing, particularly given that the business contains high-growth Watson and blockchain offerings. Bachman adds that the latest update on Cognitive segment is raising questions on whether IBM can sustain meaningful growth in operating income and free cash flows.
07/19/18
MSCO
07/19/18
NO CHANGE
Target $185
MSCO
Overweight
IBM 'relatively clean' Q2 beat puts floor under valuation, says Morgan Stanley
Morgan Stanley analyst Katy Huberty said IBM's report of a "relatively clean" beat in Q2 builds hope that the company's transformation is playing out and helps put a floor under the stock's valuation. The quarter "wasn't without blemishes," said Huberty, who pointed to cognitive revenue declines and gross margins struggling to stabilize, but another clean quarter in September could help the stock re-rate more meaningfully, she believes. Based on recent peer multiple compression, Huberty lowered her multiple for IBM and cut her price target to $185 from $198, but she keeps an Overweight rating on the shares.
07/19/18
STFL
07/19/18
NO CHANGE
Target $178
STFL
Buy
IBM report included reasons to be more optimistic, says Stifel
Stifel analyst David Grossman noted that IBM's Services revenue continued to improve in Q2 and he sees the turnaround in Services being the primary catalyst to drive IBM estimates and the stock's multiple higher over the next 12 months. While some have questioned the sustainability of revenue momentum and margin expansion, Grossman believes the market is overlooking tailwinds from restructuring actions he sees yielding about 150bp of margin tailwind in the second half and leverage from Services growth. He trimmed his price target to $178 from $182 and keeps a Buy rating on IBM shares.
07/19/18
DBAB
07/19/18
NO CHANGE
Target $150
DBAB
Hold
IBM price target lowered to $150 from $160 at Deutsche Bank
Deutsche Bank analyst Sherri Scribner lowered her price target for IBM to $150 and keeps a Hold rating on the shares. IBM last night reported Q2 sales and earnings numbers that came in slightly ahead of Street estimates, but the beat was primarily driven by the benefit of the mainframe cycle, Scribner tells investors in a research note. Performance in IBM's other three businesses were "more mixed," with sales ex-hardware not growing year-over-year in constant currency, the analyst adds. She views the stock's risk/reward as balanced at current levels.
FTI TechnipFMC
$30.94

(0.00%)

06/21/18
EXAN
06/21/18
DOWNGRADE
EXAN
Underperform
TechnipFMC downgraded to Underperform from Neutral at Exane BNP Paribas
07/17/18
FBCO
07/17/18
INITIATION
Target $38.28
FBCO
Outperform
TechnipFMC assumed with an Outperform at Credit Suisse
Credit Suisse analyst Jim Wicklund assumed coverage of TechnipFMC with an Outperform rating and $38.28 price target.
06/29/18
WELS
06/29/18
UPGRADE
Target $8
WELS
Outperform
Nabors Industries upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Judson Bailey upgraded Nabors Industries (NBR) to Outperform with an unchanged price target of $8. The analyst sees further downside risk to pressure pumping and proppant pricing and favors defensive "value" stocks that have "somewhat limited" downside earnings risk. His top four picks remain TechnipFMC (FTI), Baker Hughes (BHGE), Weatherford (WFT) and Schlumberger (SLB).
07/02/18
SBSH
07/02/18
DOWNGRADE
Target $39
SBSH
Neutral
TechnipFMC downgraded to Neutral from Buy at Citi
Citi analyst Michael Alsford downgraded TechnipFMC to Neutral and lowered his price target for the shares to $39 from $43. The analyst cites valuation for the downgrade given the stock's "strong relative outperformance" since October 2017.
URI United Rentals
$155.14

(0.00%)

07/13/18
07/13/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. VF Corp. (VFC) upgraded two notches to Buy from Underperform at BofA/Merrill with analyst Robert Ohmes saying he believes Vans momentum is sustainable and will be a "go-to-brand" for the back-to-school selling season. 2. United Rentals (URI) and Herc Holdings (HRI) were upgraded to Buy from Neutral at Buckingham. 3. Raymond James (RJF) upgraded to Buy from Neutral at Citi with analyst William Katz saying he still prefers alternative managers. 4. M.D.C. Holdings (MDC) upgraded to Neutral from Underweight at JPMorgan with analyst Michael Rehaut saying the current valuation appropriately reflects his outlook for above average order growth and margin expansion in 2018. 5. BlackRock (BLK) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Robert Lee saying shares deserve a premium valuation given its strong secular position and views the recent sell-off as a buying opportunity. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/13/18
UBSW
07/13/18
NO CHANGE
Target $196
UBSW
Buy
United Rentals looks attractive after selloff, says UBS
UBS analyst Steven Fisher believes the selloff in United Rentals shares following the company's Q1 earnings report has been overdone and he sees the shares as attractive ahead of its Q2 report given his expectations for continued end market strength and improved margins. He also expects the company to make additional deals over the next 18 months. Fisher reiterates a Buy rating and $196 price target on United Rentals shares.
07/13/18
BUCK
07/13/18
UPGRADE
BUCK
Buy
United Rentals upgraded to Buy from Neutral at Buckingham
07/03/18
STFL
07/03/18
NO CHANGE
STFL
Buy
United Rentals deal for BakerCorp presents attractive opportunity, says Stifel
Stifel analyst Stanley Elliott said he views United Rentals' deal to buy BakerCorp for $715M as an attractive transaction as it scales the company's Fluid Solutions business and was acquired at an attractive multiple. The analyst, who has been impressed by United Rentals has used its balance sheet to create scale and build a more defensible business, views the stock's valuation as compelling and maintains his Buy rating on the shares.
ABBV AbbVie
$94.40

(0.00%)

06/11/18
ARGS
06/11/18
NO CHANGE
Target $130
ARGS
Buy
AbbVie price target lowered to $130 from $145 at Argus
Argus analyst David Toung lowered his price target on AbbVie to $130, citing the clinical setback for Rova-T as a treatment for relapsing small cell lung cancer, even though he continues to expect "solid growth" from Humira, Imbruvica, and hepatitis C drugs. Toung also keeps his Buy rating on Abbvie, pointing to the company's "strong product pipeline". The analyst further states that the valuation on AbbVie stock of 11.4-times his expected FY19 EPS is attractive at just below the average industry multiple of 11.9-times given the company's strong growth prospects.
06/22/18
FBCO
06/22/18
NO CHANGE
Target $89
FBCO
Underperform
AbbVie most exposed to biosimilar risk, says Credit Suisse
Credit Suisse analyst Vamil Divan reiterated an Underperform rating on AbbVie after the FDA further ramped up its focus on biosimilars. In a research note to investors, Divan said he was "intrigued" by the FDA's decision to withdraw its September 2017 Draft Guidance focused on evaluating analytical similarity with biosimilars, and believes the agency will release "more reasonable" guidance in the coming months that will expedite the approval and uptake of biosimilars. AbbVie is most exposed to Biosimilar risk, Divan says, with Humira accounting for about 60% of its total net present value, and is cautious on AbbVie's outlook in front of biosimilar competition in the EU later this year and in the U.S. by 2023.
06/01/18
PIPR
06/01/18
NO CHANGE
PIPR
Overweight
Piper says Lilly should get some share for Olumiant with aggressive pricing
Piper Jaffray analyst Tyler Van Buren noted that the TNF step-through for Incyte (INCY) and Eli Lilly's (LLY) Olumiant potentially decreases the overall market opportunity, but he believes Olumiant will get some share of TNF failure patients given that Lilly announced it is pricing the drug "aggressively" at a potential 60% price discount to AbbVie's (ABBV) Humira. Van Buren estimates this price to be a potential 50% price discount to the other oral JAK approved for RA, Pfizer's (PFE) Xeljanz. The analyst keeps an Overweight rating on Incyte, citing the durable revenue base through the late 2020s that should come from Olumiant along with the "significant potential" he sees in its pipeline opportunities.
06/15/18
JEFF
06/15/18
NO CHANGE
JEFF
Buy
AbbVie removed from Franchise Pick list at Jefferies
Jefferies analyst Ian Hilliker removed AbbVie from his firm's Franchise Pick list but keeps a Buy rating on the shares with a reduced price target of $125. The stock "continues to have an attractive upside based on its valuation," Hilliker tells investors in a research note.
AA Alcoa
$47.90

(0.00%)

07/19/18
JEFF
07/19/18
NO CHANGE
Target $65
JEFF
Buy
Alcoa shares look undervalued despite guidance cut, says Jefferies
Jefferies analyst Christopher LaFemina says Alcoa's guidance cut on lower commodity prices, higher energy costs and U.S. tariffs offset the company's "solid" Q2 results. Alcoa continues to reduce its pension liability and is positioned to return cash to shareholders in the second half of 2018, LaFemina tells investors in a research note. He recommends buying the stock on the post-earnings weakness and keeps a Buy rating on Alcoa with a $65 price target. The analyst thinks the shares look undervalued at current levels.
06/21/18
06/21/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Alcoa (AA) initiated with a Neutral at B. Riley FBR while Century Aluminum (CENX) was initiated with a Buy. 2. Westlake Chemical (WLK) initiated with an Outperform at Bernstein while Westlake Chemical Partners (WLKP) was initiated with a Market Perform. 3. RealPage (RP) initiated with an Overweight at JPMorgan. 4. JBG Smith Properties (JBGS) initiated with a Sell at Stifel. 5. Kimberly-Clark (KMB) initiated with an Underweight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/19/18
JPMS
07/19/18
NO CHANGE
Target $80
JPMS
Overweight
Alcoa shares reflect too step a drop in aluminum prices, says JPMorgan
JPMorgan analyst Michael Gambardella lowered his estimates for Alcoa to reflect the company's guidance around the impacts from operational headwinds, tariffs and energy costs. Even with these revisions following last night's Q2 results, the analyst still expects Aloca to post "solid" EBITDA levels this year. Further, the stock price is discounting too steep of a drop in alumina and aluminum prices, Gambardella tells investors in a research note. He lowered his price target for the shares to $80 from $86 and keeps an Overweight rating on Alcoa.
07/19/18
BMOC
07/19/18
NO CHANGE
Target $75
BMOC
Outperform
Alcoa price target lowered to $75 from $80 at BMO Capital
BMO Capital analyst David Gagliano lowered his price target on Alcoa to $75 after its Q2 results, saying its adjusted EBITDA missed expectations in Q2 and the company also reduced the FY18 EBITDA guidance to reflect higher input costs. The analyst also kept his Outperform rating, noting that despite the lowered outlook, shares still trade at "only" 3.6-times his expected FY19 EBITDA on alumina/aluminum prices that are near global marginal cost. Gagliano adds that global deficit conditions in aluminum are still likely.
AXP American Express
$102.98

(0.00%)

07/19/18
BMOC
07/19/18
NO CHANGE
Target $106
BMOC
Market Perform
American Express price target raised to $106 at BMO Capital after small Q2 beat
BMO Capital analyst James Fotheringham nudged his price target on American Express to $106 from $103 following its marginal Q2 earnings beat, driven by its "better net interest income, costs, and credit". Longer term, the analyst keeps his Market Perform rating on the company given its "multiple growth headwinds", including the "discount rate decline, reinvestments, growth math, and net interest margin pressure."
07/19/18
UBSW
07/19/18
NO CHANGE
Target $115
UBSW
Buy
American Express Q2 results support buy thesis, says UBS
UBS analyst Eric Wasserstrom said the underlying Q2 results at American Express were strong and supported his thesis of sustained billed business growth. He said the billings growth offset regulatory-driven compression in GNS volume. Wassterstrom reiterated his Buy rating and $115 price target on American Express shares.
06/29/18
06/29/18
UPGRADE
Target $112

Buy
American Express upgraded to Buy after DOJ resolution at Buckingham
As previously reported, Buckingham analyst Chris Brendler upgraded American Express (AXP) to Buy from Neutral and raised his price target on the stock to $112 from $111, citing the DOJ case being resolved and evidence of "compelling momentum" across its platform. He has been surprised AmEx stock hasn't "worked" yet, but thinks investors just need more evidence that the Costco (COST) related competitive concerns are over, Brendler tells investors.
06/29/18
06/29/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. KB Home (KBH) upgraded to Buy from Underperform at BofA/Merrill with analyst John Lovallo saying KB Home's execution, margins and returns have exceeded his expectations for numerous quarters and expects solid homebuilding growth through 2020. 2. Sirius XM (SIRI) upgraded to Outperform from Market Perform at Barrington with analyst James Goss stating he is impressed with the longer-term story Sirius continues to offer and considers the recent downward move in the stock price as providing a buying opportunity. 3. Matador (MTDR) upgraded to Buy from Hold at KLR Group with analyst Gail Nicholson saying the company offers investors "solid" execution, a "strong" balance sheet and numerous catalysts which could unlock incremental value. 4. Duluth Holdings (DLTH) upgraded to Outperform from Market Perform at William Blair with analyst Dylan Carden stating he has greater conference that the direct channel will stabilize and even likely accelerate as new retail markets enter their second year. 5. American Express (AXP) upgraded to Buy from Neutral at Buckingham with analyst Chris Brendler citing the DOJ case being resolved and evidence of "compelling momentum" across its platform. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
PM Philip Morris
$82.16

(0.00%)

05/18/18
STFL
05/18/18
NO CHANGE
Target $100
STFL
Buy
Stifel highlights four potential catalysts that could boost Philip Morris shares
Stifel analyst Christopher Growe noted Philip Morris shares are trading at a valuation "well below" recent history for the stock and below Consumer Staples peers and the S&P 500. He reiterates his Buy rating on Philip Morris, highlighting four potential catalysts that the could move the stock higher, namely iQOS share growth in Japan; iQOS share growth in the EU; PMTA approval in the U.S.; and share repurchase activity. Growe keeps a $100 price target on Philip Morris shares.
07/17/18
MSCO
07/17/18
NO CHANGE
Target $102
MSCO
Overweight
Philip Morris estimates cut ahead of Q2 report at Morgan Stanley
Morgan Stanley analyst Pamela Kaufman said industry read-throughs suggest Japan HNB category growth remained tepid in Q2 and she lowered her estimates for Philip Morris ahead of its Q2 report, citing softer iQOS shipments and the negative impacts from foreign exchange rate movements. Kaufman lowered her price target on Philip Morris to $102 from $111 and keeps an Overweight rating on the shares.
07/10/18
SBSH
07/10/18
NO CHANGE
SBSH
Juul having 'profound impact' on U.S. cigarette market, says Citi
Citi analyst Adam Spielman sees "good evidence" that Juul is impacting cigarette volumes in the U.S. and will continue to do so. The analyst is also concerned that a ban on menthol cigarettes is now more likely. Further, Juul's international expansion is "yet another factor making tobacco less predictable," Spielman tells investors in a research note. The analyst believes the share declines in Altria Group (MO), British American Tobacco (BTI), Imperial Brands (IMBBY) and Philip Morris (PM) "have been more or less fair."
06/08/18
STFL
06/08/18
NO CHANGE
STFL
Buy
Philip Morris dividend increase earlier, larger than expected, says Stifel
Philip Morris's 6.5% dividend increase announced today is not only off-cycle, but also of greater magnitude than the last three increases, which have averaged just over 2%, Stifel analyst Christopher Growe tells investors in a research note. The analyst highlights the company's nearly 6% dividend yield and "deep discount" to global Consumer Staples peers. He keeps a Buy rating on Philip Morris.
BX Blackstone
$36.23

(0.00%)

06/08/18
BUCK
06/08/18
NO CHANGE
Target $46
BUCK
Buy
Aspen Insurance exit value $48-$50 per share, says Buckingham
Buckingham analyst Amit Kumar says a 1.25 to 1.3 times multiple on Aspen Insurance's (AHL) current book value gives an exit value of $48-$50 per share. Insurance Insider published a story yesterday that noted the potential finalists in the Aspen bidding process are Blackstone (BX) and Apollo (APO), Kumar tells investors in a research note. He continues to be a buyer of the stock with a Buy rating and $46 price target.
07/10/18
MUFG
07/10/18
DOWNGRADE
Target $27.5
MUFG
Neutral
Gramercy Property Trust downgraded to Neutral from Overweight at MUFG
MUFG analyst Karin Ford downgraded Gramercy Property Trust (GPT) to Neutral with an unchanged price target of $27.50 citing the company's agreement to be acquired by Blackstone (BX).
05/22/18
BARD
05/22/18
DOWNGRADE
Target $34
BARD
Neutral
LaSalle Hotel downgraded to Neutral from Outperform at Baird
Baird analyst Michael Bellisario downgraded LaSalle Hotel (LHO) to Neutral following its buyout offer from Blackstone (BX). The agreement puts the shares at full valuation and essentially matches his buyout math. As a result, he believes a higher bid is unlikely. Bellisario raised his price target to $34 from $32 on LaSalle Hotel shares.
05/21/18
LEHM
05/21/18
UPGRADE
LEHM
Equal Weight
LaSalle Hotel upgraded to Equal Weight from Underweight at Barclays
Barclays analyst Felicia Kantor Hendrix upgraded LaSalle Hotel (LHO) to Equal Weight from Underweight following the company's announcement that it has agreed to be acquired by Blackstone (BX).
XLP Consumer Staples Sector SPDR
$52.55

(0.00%)

07/09/18
MSCO
07/09/18
NO CHANGE
MSCO
Morgan Stanley suggests getting more defensive, downgrades Tech to underweight
Morgan Stanley equity strategist Michael Wilson believes the S&P 500 could trade to 2,800-2,825 in the "very near-term," but is recommending investors use such a move higher to reduce portfolio beta and risk as he continues to expect an "aggressive rotation" toward defensive sectors at some point. Given his view of a growing probability for sustained defensive leadership, Wilson downgraded Small caps to equal weight and Technology to underweight. He also upgraded Consumer Staples and Telecom Services to equal weight from underweight.

TODAY'S FREE FLY STORIES

PENN

Penn National

$31.77

0.71 (2.29%)

10:33
08/16/18
08/16
10:33
08/16/18
10:33
Hot Stocks
Penn National announces launch dates for sports betting at Mississippi casinos »

Penn National Gaming…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:30
08/16/18
08/16
10:30
08/16/18
10:30
General news
EIA natural gas storage change for week ending August 10 »

Gas inventories 33 Bcf…

CTL

CenturyLink

$22.96

0.48 (2.14%)

10:30
08/16/18
08/16
10:30
08/16/18
10:30
Options
Sweep buyer of CenturyLink in the money puts as shares reach 52-week highs »

Sweep buyer of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBNY

Signature Bank

$114.29

1.53 (1.36%)

10:29
08/16/18
08/16
10:29
08/16/18
10:29
Hot Stocks
Signature Bank announces special meeting to approve stock buyback program »

Signature Bank announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 29

    Oct

10:20
08/16/18
08/16
10:20
08/16/18
10:20
General news
Market opens sharply higher on renewed trade hopes »

Stock futures were…

ROK

Rockwell Automation

$172.79

1.13 (0.66%)

10:20
08/16/18
08/16
10:20
08/16/18
10:20
Options
Call buyer in Rockwell as shares see strength »

Call buyer in Rockwell as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
08/16/18
08/16
10:17
08/16/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZBH

Zimmer Biomet

$122.72

0.03 (0.02%)

10:16
08/16/18
08/16
10:16
08/16/18
10:16
Hot Stocks
KFx Medical, Zimmer Biomet enter into license agreement »

KFx Medical announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
08/16/18
08/16
10:16
08/16/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
08/16/18
08/16
10:15
08/16/18
10:15
General news
Breaking General news story  »

Week of 8/10 EIA Natural…

POST

Post Holdings

$96.51

1.73 (1.83%)

, SYK

Stryker

$168.57

1.735 (1.04%)

10:12
08/16/18
08/16
10:12
08/16/18
10:12
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

POST

Post Holdings

$96.51

1.73 (1.83%)

SYK

Stryker

$168.57

1.735 (1.04%)

AVEO

Aveo Pharmaceuticals

$2.26

0.085 (3.91%)

UXIN

Uxin

$5.58

0.315 (5.98%)

ACRX

AcelRx

$2.95

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 22

    Aug

  • 23

    Aug

  • 04

    Sep

  • 12

    Sep

AZN

AstraZeneca

$38.35

-0.1 (-0.26%)

, CX

Cemex

$6.80

0.005 (0.07%)

10:12
08/16/18
08/16
10:12
08/16/18
10:12
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

AZN

AstraZeneca

$38.35

-0.1 (-0.26%)

CX

Cemex

$6.80

0.005 (0.07%)

CVE

Cenovus Energy

$8.97

0.015 (0.17%)

NANO

Nanometrics

$41.46

-3.74 (-8.27%)

COTY

Coty

$11.37

-0.06 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 21

    Aug

  • 25

    Aug

  • 28

    Aug

  • 09

    Oct

LULU

Lululemon

$127.75

1.27 (1.00%)

, KMB

Kimberly-Clark

$117.47

1 (0.86%)

10:12
08/16/18
08/16
10:12
08/16/18
10:12
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

LULU

Lululemon

$127.75

1.27 (1.00%)

KMB

Kimberly-Clark

$117.47

1 (0.86%)

ERJ

Embraer

$19.49

0.855 (4.59%)

FTI

TechnipFMC

$28.19

0.59 (2.14%)

AVLR

Avalara

$37.90

3.22 (9.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 30

    Aug

  • 12

    Sep

RADA

RADA Electronic

$2.55

0.01 (0.39%)

10:10
08/16/18
08/16
10:10
08/16/18
10:10
Initiation
RADA Electronic initiated  »

RADA Electronic initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$43.82

0.35 (0.81%)

10:10
08/16/18
08/16
10:10
08/16/18
10:10
Options
Another utility name with one day call buying »

Another utility name with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LULU

Lululemon

$127.16

0.68 (0.54%)

, KMB

Kimberly-Clark

$117.91

1.44 (1.24%)

10:06
08/16/18
08/16
10:06
08/16/18
10:06
Recommendations
Fly Intel: Today's top analyst calls on Wall Street »

Check out today's…

LULU

Lululemon

$127.16

0.68 (0.54%)

KMB

Kimberly-Clark

$117.91

1.44 (1.24%)

COTY

Coty

$11.34

-0.09 (-0.79%)

ATVI

Activision Blizzard

$69.47

0.2 (0.29%)

NKE

Nike

$80.12

0.56 (0.70%)

UA

Under Armour

$19.22

0.19 (1.00%)

UAA

Under Armour

$20.79

0.2 (0.97%)

VFC

VF Corp.

$92.13

-0.17 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 30

    Aug

  • 04

    Sep

  • 12

    Sep

  • 12

    Sep

  • 13

    Sep

C

Citi

$69.49

0.85 (1.24%)

, CAT

Caterpillar

$134.50

2.49 (1.89%)

10:03
08/16/18
08/16
10:03
08/16/18
10:03
Hot Stocks
Citi Retail Services announces long-term agreement with Caterpillar Financial »

Citi Retail Services (C)…

C

Citi

$69.49

0.85 (1.24%)

CAT

Caterpillar

$134.50

2.49 (1.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jan

  • 15

    Apr

  • 13

    Jul

  • 15

    Oct

GTN

Gray Television

$16.40

-0.05 (-0.30%)

, CBS

CBS

$52.89

0.09 (0.17%)

10:02
08/16/18
08/16
10:02
08/16/18
10:02
Hot Stocks
Gray Television to sell WSWG-TV in Albany, Georgia »

Gray Television (GTN)…

GTN

Gray Television

$16.40

-0.05 (-0.30%)

CBS

CBS

$52.89

0.09 (0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 27

    Sep

GM

General Motors

$36.49

0.55 (1.53%)

, RDS.A

Royal Dutch Shell

$63.18

0.95 (1.53%)

10:02
08/16/18
08/16
10:02
08/16/18
10:02
Hot Stocks
GM, Shell deliver nationwide in-dash fuel payment »

Shell Oil Company (RDS.A)…

GM

General Motors

$36.49

0.55 (1.53%)

RDS.A

Royal Dutch Shell

$63.18

0.95 (1.53%)

RDS.B

Royal Dutch Shell

$65.20

0.92 (1.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Aug

UVXY

ProShares Trust Ultra VIX Short Term Futures ETF

$9.12

-0.63 (-6.46%)

10:00
08/16/18
08/16
10:00
08/16/18
10:00
Hot Stocks
ProShares Trust Ultra VIX Short Term Futures ETF falls -6.6% »

ProShares Trust Ultra VIX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNL

Global Net Lease

$20.61

-1.47 (-6.66%)

10:00
08/16/18
08/16
10:00
08/16/18
10:00
Hot Stocks
Global Net Lease falls -6.6% »

Global Net Lease is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

DDS

Dillard's

$74.93

-8.05 (-9.70%)

10:00
08/16/18
08/16
10:00
08/16/18
10:00
Hot Stocks
Dillard's falls -9.8% »

Dillard's is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATV

Acorn International

$17.84

(0.00%)

10:00
08/16/18
08/16
10:00
08/16/18
10:00
Hot Stocks
Acorn International rises 10.1% »

Acorn International is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EA

Electronic Arts

$128.36

0.3 (0.23%)

10:00
08/16/18
08/16
10:00
08/16/18
10:00
Options
Electronic Arts with repeat option action late yesterday »

Electronic Arts with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 12

    Sep

  • 12

    Sep

  • 13

    Sep

WUBA

58.com

$65.22

6.63 (11.32%)

10:00
08/16/18
08/16
10:00
08/16/18
10:00
Hot Stocks
58.com rises 11.2% »

58.com is up 11.2%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 10

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.